ATC Group: A08AX Other antiobesity drugs

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A08AX in the ATC hierarchy

Group A08AX contents

Code
Title

Active ingredients in A08AX

Active Ingredient
Description

Rimonabant is a selective cannabinoid-1 receptor (CB1) antagonist that inhibits the pharmacological effects of cannabinoid agonists in vitro and in vivo. The endocannabinoid system is a physiological system present in brain and peripheral tissues (including adipocytes) that affects energy balance, glucose and lipid metabolism and body weight, and in neurons of the mesolimbic system modulates the intake of highly palatable, sweet or fatty foods.

Related product monographs

Title
Information Source
Document Type
 
European Medicines Agency (EU)
MPI, EU: SmPC